Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 3Cytokine Release Syndrome 2Schwannomatosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Neurilemmoma 1Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Large Granular Lymphocytic 1Immunoglobulin Light-chain Amyloidosis 1Chronic Pain 1Burkitt Lymphoma 1Advanced Malignant Solid Neoplasm 1

Interventions

Surveys and Questionnaires 3Lidocaine 2Ketamine 2Educational Status 2Dexmedetomidine 2ziconotide 1siltuximab 1erenumab 1Yoga 1Telemedicine 1Standard of Care 1Sodium Chloride 1Saline Solution 1Phlebotomy 1Patient Education as Topic 1Pain Management 1Nalbuphine 1Motivational Interviewing 1Morphine 1Control Groups 1Cognitive Behavioral Therapy 1Bupivacaine 1Botulinum Toxins, Type A 1Anesthesia, General 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chronic Pain × siltuximab × 1 year × Clear all
NCT05684692 2026-04-23

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Massachusetts General Hospital

Phase 2 Recruiting
40 enrolled

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡